Advertisement
Screener

COMPASS PATHWAYS PLC (CMPS) ROA

COMPASS PATHWAYS PLC (CMPS) ROA

  • 2026-06-30: ROA -78.12%.
  • 2026-03-31: ROA -33.62%.
  • 2025-12-31: ROA -136.85%.
  • 2025-09-30: ROA -92.84%.

Complete source-backed roa history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-78.12%
2026-03-31-33.62%
2025-12-31-136.85%
2025-09-30-92.84%
2025-06-30-47.05%
2025-03-31-43.18%
2024-12-31-72.60%
2024-09-30-58.35%
2024-06-30-49.98%
2024-03-31-41.89%
2023-12-31-42.92%
2023-09-30-39.08%
2023-06-30-48.53%
2023-03-31-54.55%
2022-12-31-46.38%
2022-09-30-38.41%
2022-06-30-35.08%
2022-03-31-29.47%
2021-12-31-23.84%
2021-09-30-20.62%
2021-06-30-19.36%
2020-12-31-29.87%

Annual ROA

DateROA
2025-12-31-136.85%
2024-12-31-72.60%
2023-12-31-42.92%
2022-12-31-46.38%
2021-12-31-23.84%
2020-12-31-29.65%
2019-12-31-60.55%

Similar stocks

Stock NameCountryMarket CapPE Ratio
ANI PHARMACEUTICALS INC (ANIP)United States$1.810B18.77
Septerna, Inc. (SEPN)United States$1.783B-63.01
Xencor Inc (XNCR)United States$1.776B-7.33
Zymeworks Inc. (ZYME)United States$1.902B-12.44
Eton Pharmaceuticals, Inc. (ETON)United States$1.701B80.74
Sarepta Therapeutics, Inc. (SRPT)United States$1.941B-13.89
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38
Biohaven Ltd. (BHVN)United States$1.990B-3.83
Xeris Biopharma Holdings, Inc. (XERS)United States$1.632B-80.10
Stoke Therapeutics, Inc. (STOK)United States$1.630B-9.82